Breaking Finance News

Halyard Health Inc (NYSE:HYH) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.

Zacks Investment Research has downgraded Halyard Health Inc (NYSE:HYH) to Hold in a statement released on Wednesday October 05, 2016.

On 8/10/2016, Deutsche Bank released a statement for Halyard Health Inc (NYSE:HYH) bumped up the target price from $36.00 to $41.00 that suggested an upside of 0.12%.

Boasting a price of $34.14, Halyard Health Inc (NYSE:HYH) traded -0.23% lower on the day. With the last stock price close up 5.08% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Halyard Health Inc has recorded a 50-day average of $35.25 and a two hundred day average of $32.65. Volume of trade was down over the average, with 306,120 shares of HYH changing hands under the typical 388,786

Performance Chart

Halyard Health Inc (NYSE:HYH)

With a total market value of $0, Halyard Health Inc has with a one year low of $22.76 and a one year high of $37.31 .

A total of 5 equity analysts have released a research note on HYH. One equity analyst rating the company a strong buy, two equity analysts rating the company a buy, two equity analysts rating the company a hold, one equity analyst rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $29.40.

More About Halyard Health Inc (NYSE:HYH)

Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. The S&IP segment's product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. The S&IP segment is also a provider of education to prevent healthcare-associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. Its products include QUICK CHECK, SMART-FOLD, POWERGUARD, MICROCOOL and FLUIDSHIELD.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *